← SynDRA
LINERIXIBAT
SynDRA canonical compound SYN0037381 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | SLC10A2 |
|---|
| Mechanism of action | bile acid transporter inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- SLC10A2 INHIBITOR
- Ileal bile acid transporter inhibitor
- bile acid transporter inhibitor
Cross-references
Synonyms
- Gsk-2330672
- GSK2330672
- GSK 2330672
- linerixibatum
- RefChem:153530
- Iinerixibat
- Linerixibat [USAN]
- MFCD28386358
- BDBM50434858
- CZGVOBIGEBDYTP-VSGBNLITSA-N
- UNII-386012Z45S
- Lynavoy (TN)
- LINERIXIBAT [INN]
- LINERIXIBAT [JAN]
- Linerixibat (JAN/USAN)
- LINERIXIBAT [WHO-DD]
- orb1303485
- SCHEMBL2586025
- SCHEMBL29429786
- BDBM47370
- C28H38N2O7S
- EX-A1180
- VDC98269
- WHO 10729
- AKOS030526427
- CS-5447
- AC-36158
- AS-35059
- HY-16643
- NS00073125
- T3978
- D11539
- US9040518, 26
- BRD-K05858796-001-01-7
- GSK-2330672
- LYNAVOY
Look up LINERIXIBAT in the interactive SynDRA portal →